![Brock Metcalf](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brock Metcalf
Founder at Reference Capital Management LLC
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Gilbert N. Miller | M | - |
Virogenomics BioDevelopment, Inc.
![]() Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR.
Artielle ImmunoTherapeutics, Inc.
![]() Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | 23 years |
James Hicks | M | 77 |
Virogenomics BioDevelopment, Inc.
![]() Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | 23 years |
Peter C. M. McWilliams | M | - |
Artielle ImmunoTherapeutics, Inc.
![]() Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | - |
Jeff King | M | - |
Virogenomics BioDevelopment, Inc.
![]() Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | 23 years |
Renee Shirley | F | - |
Virogenomics BioDevelopment, Inc.
![]() Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | 23 years |
Halina Offner | M | - |
Artielle ImmunoTherapeutics, Inc.
![]() Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | 20 years |
Arthur A. Vandenbark | M | - |
Artielle ImmunoTherapeutics, Inc.
![]() Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | 20 years |
Wayne L. Embree | M | - |
Reference Capital Management LLC
![]() Reference Capital Management LLC Investment ManagersFinance Reference Capital Management LLC (Reference Capital) is a venture capital firm founded in 2006 by Wayne L. Embree and Brock Metcalf. The firm is headquartered in Portland, Oregon. | 38 years |
James W. Korfhage | M | - |
Virogenomics BioDevelopment, Inc.
![]() Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | - |
David C.E Williams | M | - |
Reference Capital Management LLC
![]() Reference Capital Management LLC Investment ManagersFinance Reference Capital Management LLC (Reference Capital) is a venture capital firm founded in 2006 by Wayne L. Embree and Brock Metcalf. The firm is headquartered in Portland, Oregon. | 13 years |
Rob Wiltbank | M | - |
Virogenomics BioDevelopment, Inc.
![]() Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | - |
Shahab Fatheazam | M | 72 |
Artielle ImmunoTherapeutics, Inc.
![]() Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | 20 years |
William Newman | M | - |
Virogenomics BioDevelopment, Inc.
![]() Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Daniel Mauney | M | - |
Virginia Polytechnic Institute & State University
| 6 years |
Trey Snow | M | - |
Virginia Polytechnic Institute & State University
| 6 years |
Lisa Marie Roberts | F | 57 |
Virginia Polytechnic Institute & State University
| 6 years |
Robert Goetz | M | - |
Virginia Polytechnic Institute & State University
| 6 years |
Christopher Baker | M | - |
Virginia Polytechnic Institute & State University
| 3 years |
David Meier | M | - |
Virginia Polytechnic Institute & State University
| 7 years |
Noel Heiks | F | 53 |
Virginia Polytechnic Institute & State University
| 9 years |
Steve Fredrick | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Charles D. Johnson | M | - |
Virginia Polytechnic Institute & State University
| 6 years |
Bryan Tinsley | M | - |
Virginia Polytechnic Institute & State University
| 6 years |
Jian-Zhong Qian | M | 76 |
Virginia Polytechnic Institute & State University
| 5 years |
Paul S. Kramer | M | - |
Virginia Polytechnic Institute & State University
| 5 years |
Charles Walker Dorroh | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Robert Taylor | M | - |
Virginia Polytechnic Institute & State University
| 10 years |
David J. Sturek | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Howard N. Shipley | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Christopher L. Symanoskie | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Jay Parikh | M | 51 |
Virginia Polytechnic Institute & State University
| 4 years |
Matt Fleming | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Uma Jayaram | M | - |
Virginia Polytechnic Institute & State University
| 3 years |
Kelley Williamson | F | - |
Virginia Polytechnic Institute & State University
| 4 years |
Gregory Stanton Kaplan | M | - |
Virginia Polytechnic Institute & State University
| 2 years |
Jill Zelter | F | - |
Virginia Polytechnic Institute & State University
| 4 years |
Ken Lanford | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Kord J. Wissman | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
James D. Ross | M | 75 |
Virginia Polytechnic Institute & State University
| 4 years |
Robert Reed | M | 59 |
Virginia Polytechnic Institute & State University
| 4 years |
Johny Tjoa | M | - |
Virginia Polytechnic Institute & State University
| 2 years |
Burke Jason | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Mark Newton | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Liang Qiang | M | 59 |
Virginia Polytechnic Institute & State University
| 6 years |
Nicole Vipperman | F | - |
Virginia Polytechnic Institute & State University
| 4 years |
Michael C. Brown | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Chip Devine | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Hal Frankel | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Christopher Thomas | M | - |
Virginia Polytechnic Institute & State University
| 10 years |
Geoffrey Grammer | M | 53 |
Virginia Polytechnic Institute & State University
| 4 years |
James Michael Shapaker | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Edward Baron | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Paul Evangel Petera | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Todd Meredith | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Jennifer Mertz | F | - |
Virginia Polytechnic Institute & State University
| 4 years |
Carla R. Stoner | F | 62 |
Virginia Polytechnic Institute & State University
| 4 years |
Denise C. Whennen | F | - |
Virginia Polytechnic Institute & State University
| 4 years |
Chris Massey | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
John F. Naber | M | - |
Virginia Polytechnic Institute & State University
| 3 years |
Norman Adkins | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Jonathan Ebinger | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Robert L. Gunter | M | - |
Virginia Polytechnic Institute & State University
| 2 years |
Keith A. Whitener | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Russell Thomas | M | 61 |
Virginia Polytechnic Institute & State University
| 4 years |
Stephanie Reese | F | - |
Virginia Polytechnic Institute & State University
| 4 years |
Brian Callaghan | M | 53 |
Virginia Polytechnic Institute & State University
| 4 years |
Ashraf Lotfi | M | 63 |
Virginia Polytechnic Institute & State University
| 3 years |
Raman Khanna | M | - |
Virginia Polytechnic Institute & State University
| 1 years |
Ian Patrick Sobieski | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
P. Christopher Holland | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Barbara A. Murphy | F | 86 |
Virginia Polytechnic Institute & State University
| 4 years |
Mark Peter Roemer | M | 60 |
Virginia Polytechnic Institute & State University
| 5 years |
Jeff Wlodarczak | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Michael Cole | M | - |
Virginia Polytechnic Institute & State University
| 5 years |
Edwin Sheridan | M | 54 |
Virginia Polytechnic Institute & State University
| 4 years |
Bryan D. Smith | M | 54 |
Virginia Polytechnic Institute & State University
| 4 years |
Gregory Thomas | M | 58 |
Virginia Polytechnic Institute & State University
| 4 years |
Christopher W. Shean | M | 58 |
Virginia Polytechnic Institute & State University
| 4 years |
Michael Glasgow | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
J. David Craig | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Scott Harlan | M | - |
Virginia Polytechnic Institute & State University
| 5 years |
Rachel Chiang | F | 56 |
Virginia Polytechnic Institute & State University
| 4 years |
James Bright | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
A. Leigh Powell | M | 61 |
Virginia Polytechnic Institute & State University
| 2 years |
Graham Stead | M | - |
Virginia Polytechnic Institute & State University
| 5 years |
Andrew W. Whipple | M | 60 |
Virginia Polytechnic Institute & State University
| 4 years |
Craig Edward Barker | M | 63 |
Virginia Polytechnic Institute & State University
| 1 years |
Jeff Phillips | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
William Brewster | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Michael Natchus | M | - |
Virginia Polytechnic Institute & State University
| 3 years |
Thomas L. Payne | M | - |
Virginia Polytechnic Institute & State University
| - |
M. Shane Harvey | M | 54 |
Virginia Polytechnic Institute & State University
| 4 years |
Lisa Healy | F | - |
Virginia Polytechnic Institute & State University
| 4 years |
Sid Adkins | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Wm Braun Jones | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Michael R. Bedsaul | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
William N. Colonna | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Scott Fletcher | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Mike A. Hincher | M | - |
Virginia Polytechnic Institute & State University
| 5 years |
Bill Roller | M | - |
Virginia Polytechnic Institute & State University
| 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Brock Metcalf
- Personal Network